IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease

Neurology

Volumn 60, Issue 8, 2003, Pages 1320-1327

  Jernigan, M ^a   Morcos, Y ^a   Lee, S M ^a,b   Dohan Jr , F C ^a   Raine, C ^c   Levin, M C ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; NUCLEAR RNA;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARCUATE NUCLEUS; ARTICLE; AUTOPSY; BRAIN INJURY; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE ASSOCIATION; FRONTAL CORTEX; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; HYPOTHESIS; IMMUNOGLOBULIN DEPOSITION; IMMUNOREACTIVITY; MEDIAL LEMNISCUS; MEDULLA OBLONGATA; MESENCEPHALON; MOLECULAR MIMICRY; NERVE CELL; NERVE FIBER; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PONS; PRIORITY JOURNAL; PYRAMIDAL TRACT; SENSORY SYSTEM; SERUM; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; WHITE MATTER;

EID: 0037461354     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000059866.03880.BA     Document Type: Article

References (34)

1. Levin M, Jacobson S. HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. J Neurovirol 1997;3:126-140.
2. Izumo S, Umehara F, Osame M. HTLV-1-associated myelopathy. Neuropathology 2000;20(suppl):S65-S68.
3. Suga R, Tobimatsu S, Kira J, Kato M. Motor and somatosensory evoked potential findings in HTLV-I associated myelopathy. J Neurol Sci 1999;167:102-106.
4. Moore G, Traugott U, Scheinberg L, Raine C. Tropical spastic paraparesis: a model of virus-induced cytotoxic T-cell mediated demyelination? Ann Neurol 1989;26:523-530.
5. Wu E, Dickson D, Jacobson S, Raine C. Neuroaxonal dystrophy in HTLV-I associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations. Acta Neuropathol 1993;86:224-235.
6. Jacobson S, Levin M, Utz U, Drew P. Infectious immune disorders. HTLV-I. In: Antel J, Birnbaum G, Hartung H, eds. Neuroimmunology. Cambridge: Blackwell Science, 1998;204-217.
7. Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-1 proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-1 carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998;4:586-593.
8. Bangham CRM. The immune response to HTLV-1. Curr Opin Immunol 2000;12:397-402.
9. Levin M, Krichavsky M, Berk J, et al. Neuronal molecular mimicry in immune mediated neurologic disease. Ann Neurol 1998;44:87-98.
10. Levin MC, Lee SM, Kalume F, et al. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med 2002;8:509-513.
11. Lassek AM. The human pyramidal tract. II. A numerical investigation of the Betz cells of the motor area. Arch Neurol Psychiatry 1940;44:718-724.
12. Lehky T, Fox C, Koenig S, et al. Detection of human T lymphotropic virus type I (HTLV-1) tax RNA in the central nervous system of HTLV-1 associated myelopathy/tropical spastic paraparesis by in situ hybridization. Ann Neurol 1995;37:246-254.
13. Haines DE. Neuroanatomy. An atlas of structures, sections and systems. Fifth ed. Philadelphia: Lippincott, Williams & Wilkins, 2000.
14. Wucherpfennig K, Catz I, Hausmann S, Strominger F, Steinman L, Warren K. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. J Clin Invest 1997;100:1114-1122.
15. Warren K, Catz I, Steinman L. Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B-cell epitope and a model of its features. Proc Natl Acad Sci USA 1995;92:11061-11065.
16. Matsuzaki T, Nakagawa M, Nagai M, et al. HTLV-I-associated myelopathy/tropical spastic paraparesis with amyotrophic lateral sclerosis-like manifestations. J Neurovirol 2000;6:544-548.
17. Kamma H, Portman DS, Dreyfuss G. Cell type-specific expression of hnRNP proteins. Exp Cell Res 1995;221:187-196.
18. Krecic AM, Swanson MS. hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 1999;11:363-371.
19. Jacobson S, Shida H, McFarlin D, Fauci A, Koenig S. Circulating CD8+ cytotoxic lymphocytes specific for HTLV-1 in patients with HTLV-1 associated neurological disease. Nature 1990;348:245-248.
20. Lal R, Giam C, Coligan J, Rudolph D. Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T-cell lymphotropic virus type I associated myelopathy. J Infect Dis 1994;169:496-503.
21. Romero I, Prevost M, Perret E, et al. Interactions between brain endothelial cells and human T-cell leukemia virus type 1 infected lymphocytes: mechanisms of viral entry into the central nervous system. J Virol 2000;74:6021-6030.
22. Giraudon P, Szymocha R, Buart S, et al. T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance of HTLV-I-induced neurologic disease. J Immunol 2000;164:2718-2727.
23. Umehara F, Okada Y, Fujimoto N, Abe M, Izumo S, Osame M. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I associated myelopathy. J Neuropathol Exp Neurol 1998;57:839-849.
24. Noseworthy J, Lucchinetti C, Rodgriguez M, Weinshenker B. Multiple sclerosis. N Engl J Med 2000;343:938-952.
25. Carson JH, Kwon S, Barbarese E. RNA trafficking in myelinating cells. Curr Opin Neurobiol 1998;8:607-612.
26. Munro TP, Magee RJ, Kidd GJ, et al. Mutational analysis of a heterogeneous nuclear ribonucleoprotein A2 response element for RNA trafficking. J Biol Chem 1999;274:34389-34395.
27. Tonra J, Reiseter B, Kolbeck R, et al. Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis. J Comp Neurol 2001;430:131-144.
28. Chen W, Elias RV, Cao W, Lerious V, McGinnis JF. Anti-recoverin antibodies cause the apoptotic death of mammalian photoreceptor cells in vitro. J Neurosei Res 1999;57:706-718.
29. Chen W, Cao W, Achyuthan AM, McGinnis JF. In vitro inhibition of antirecoverin immunoglobulin-mediated death of mammalian photoreceptor cells. J Neurosci Res 2001;63:116-123.
30. Adamus G, Machnicki M, Seigel GM. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy. Invest Ophthalmol Vis Sci 1997;38:283-291.
31. Adamus G, Machnicki M, Elerding H, Sugden B, Blocker Y, Fox D. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmun 1998;11:523-533.
32. Buckanovich R, Posner J, Darnell R. Nova, the paraneoplastic Ri antigen, is homologous to an RNA binding protein and is specifically expressed in the developing motor system. Neuron 1993;11:657-672.
33. Hollsberg P, Hafler D. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 1993;328:1173-1182.
34. Moritoyo T, Reinhart T, Moritoyo H, et al. Human T-lymphotropic virus type I associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol 1996;40:84-90.